VanEck Biotech ETF
BBH
102 hedge funds and large institutions have $129M invested in VanEck Biotech ETF in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 7 closing their positions.
271% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 7
112% more call options, than puts
Call options by funds: $1.37M | Put options by funds: $646K
77% more capital invested
Capital invested by funds: $73M → $129M (+$56.4M)
75% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 16
23% more funds holding
Funds holding: 83 → 102 (+19)
4.58% more ownership
Funds ownership: 22.78% → 27.36% (+4.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Pinnacle Advisory Group
Columbia,
Maryland
|
+$17.7M |
| 2 |
Morgan Stanley
New York
|
+$3.36M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.25M |
| 4 |
LPL Financial
San Diego,
California
|
+$2.05M |
| 5 |
BRC
BHF RG Capital
Scottsdale,
Arizona
|
+$1.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$4.57M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$440K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$361K |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$251K |
| 5 |
CG
Caprock Group
Boise,
Idaho
|
-$209K |
BBH Hedge Fund Activity: Q2 2020 in Review
102 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2020, worth a combined $129M — up 77% from $73M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new BBH positions and 7 closed out — a net gain of 19 holders — while 28 added to existing stakes and 16 trimmed.
The largest buyer was Pinnacle Advisory Group, adding an estimated $17.7M. The largest seller was Bank of America, cutting an estimated $4.57M.
- 102 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2020, up from 83 in Q1 2020.
- Funds reported $129M of VanEck Biotech ETF stock for Q2 2020, up 77% quarter-over-quarter.
- 26 funds opened new VanEck Biotech ETF positions in Q2 2020 and 7 closed out, a net change of +19 holders.
- The largest VanEck Biotech ETF buyer in Q2 2020 was Pinnacle Advisory Group, an estimated $17.7M added.
- The largest VanEck Biotech ETF seller in Q2 2020 was Bank of America, an estimated $4.57M sold.
Based on aggregated 13F filings for Q2 2020.